DECURSIN

/ INGREDIENTS / By
  1. (S)-(+)-Decursin and its Analogues as Inhibitors of Cytokines Secretion Induced by DpE in THP-1/EoL-1 Cell Line
  2. [P8-06] Effect of Decursin on the Body weight and Glucose tolerance in C57/BL/6 Mice Fed High Fat Diet
  3. 183: Decursin affects Wnt/beta catenin pathway on prostate cancer cell lines.
  4. 3D-QSAR Study of Melanin Inhibiting (S)-(+)-Decursin and its Analogues by Pharmacophore Mapping
  5. A (S)-(+)-Decursin derivative,(S)-(+)-3-(3, 4-dihydroxy-phenyl)-acrylic acid 2, 2-dimethyl-8-oxo-3, 4-dihydro-2H, 8H-pyrano [3, 2-g]-chromen-3-yl-ester, attenuates the …
  6. A COMPOSITION COMPRISING NOVEL (+)-Decursin-ETHER DERIVATIVE FOR TREATING AND PREVENTING ATOPIC DERMATITIS DISEASE
  7. A novel (S)-(+)-Decursin derivative,(S)-(+)-3-(3, 4-dihydroxy-phenyl)-acrylic acid 2, 2-dimethyl-8-oxo-3, 4-dihydro-2H, 8H-pyrano [3, 2-g] chromen-3-yl-ester, inhibits …
  8. A novel anticancer agent, Decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells
  9. A novel anticancer agent, Decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells: Yim D, Singh RP, Agarwal C, Lee S, Chi H, Agarwal R …
  10. A novel anticancer agent, Decursin, induces G1 arrest and apoptosis in human prostate carcinoma DU145 cells
  11. A Novel Anticancer Agent, Decursin, Induces G1 Arrest in Human Prostate Carcinoma DU-145
  12. A novel derivative of Decursin, CSL‐32, blocks migration and production of inflammatory mediators and modulates PI3K and NF‐κB activities in HT1080 cells
  13. A synthetic Decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo
  14. Absorption, distribution, metabolism, and excretion of Decursin and Decursinol angelate from Angelica gigas Nakai
  15. Abstract LB-428: Decursin inhibits advanced human prostate tumor xenograft growth involving antiproliferative and antiangiogenic mechanisms
  16. Analytical Validation of Decursin in Aerial Parts of Angelica gigas Nakai
  17. Angelica gigas Nakai and Decursin downregulate Myc expression to promote cell death in B-cell lymphoma
  18. Anti-Angiogenic Effect of Decursin on Retinal Neovasularization of Oxygn-Induced Retinopathy
  19. Anti-tumor activities of Decursinol angelate and Decursin fromAngelica gigas
  20. Antibacterial activity of Decursin from Streptomyces sp. GMT-8; an endophyte in Zingiber officinale Rosc.
  21. Availability of Decursin and Decursinol Angelate and antioxidant activity in the seeds of Angelica gigas Nakai
  22. Axial conformation of 3-methyl-2-butenoyl group in pyranocoumarin ring endows biological activity of (+)-Decursin
  23. Biopharmaceutical characterization of Decursin and their derivatives for drug discovery
  24. Biotransformation of plant secondary metabolite Decursin by Mycobacterium sp. PYR1001
  25. Changes in the growth characteristics and the content of Decursin and Decursinol angelate in Angelica gigas Nakai by mineral and hormonal agent treatment
  26. Cognitive-Enhancing Activity of Decursin Derivatives
  27. Comparison of skin sensitization potentials of Decursin with different purities by evaluating the expression of surface markers on THP-1 cells (초)
  28. Compositions for urinary dysfunction and edema containing Decursin and/or Decursinol angelate, or angelica extract containing Decursin and/or Decursinol angelate
  29. Computational approaches to predict binding interactions between mammalian tyrosinases and (S)-(+)-Decursin and its analogues as potent inhibitors
  30. Cytochrome P450 isoforms in the metabolism of Decursin and Decursinol angelate from Korean Angelica
  31. Decursin and Decursinol angelate affect spermatogenesis in the adult rat at oral administration
  32. Decursin and Decursinol angelate from Angelica gigas Nakai induce apoptosis via induction of TRAIL expression on cervical cancer cells
  33. Decursin and Decursinol angelate improve wound healing by upregulating transcription of genes encoding extracellular matrix remodeling proteins, inflammatory …
  34. Decursin and Decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells
  35. Decursin and Decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells
  36. Decursin and Decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway
  37. Decursin and Decursinol angelate selectively inhibit NADH-fumarate reductase of Ascaris suum
  38. Decursin and Decursinol Angelate Suppress Adipogenesis through Activation of β-catenin Signaling Pathway in Human Visceral Adipose-Derived Stem Cells
  39. Decursin and Decursinol angelate-rich Angelica gigas Nakai extract suppresses de novo lipogenesis and alleviates nonalcoholic fatty liver disease and dyslipidemia …
  40. Decursin and Decursinol angelate: molecular mechanism and therapeutic potential in inflammatory diseases
  41. Decursin and Decursinol from Angelica gigas Inhibit the Lung Metastasis of Murine Colon Carcinoma
  42. Decursin and Decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase
  43. Decursin and doxorubicin are in synergy for the induction of apoptosis via STAT3 and/or mTOR pathways in human multiple myeloma cells
  44. Decursin and doxorubicin are in synergy for the induction of apoptosis via STAT3 and/or mTOR pathways in human multiple myeloma cells.
  45. Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells
  46. Decursin and Z-ligustilide in Angelica tenuissima root extract fermented by Aspergillus oryzae display anti-pigment activity in melanoma cells
  47. Decursin Attenuate CCl4-induced Liver Fibrogenesis
  48. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD (P) H oxidase activation and Smad signaling in vivo and in vitro
  49. Decursin attenuates the amyloid‐β‐induced inflammatory response in PC12 cells via MAPK and nuclear factor‐κB pathway
  50. Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathway
  51. Decursin derivative-004 protect renal cell damage via p38 MARK inhibition
  52. Decursin derivatives with increased in vivo stability suppress androgen receptor signaling and prostate cancer cell growth: Structure-bioactivity relationship
  53. Decursin enhances TRAIL‐induced apoptosis through oxidative stress mediated‐endoplasmic reticulum stress signalling in non‐small cell lung cancers
  54. Decursin exerts anti‐cancer activity in MDA‐MB‐231 breast cancer cells via inhibition of the Pin1 activity and enhancement of the Pin1/p53 association
  55. Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice
  56. Decursin from Angelica gigas Nakai Blocks hKv1. 5 Channel
  57. Decursin from Angelica gigas Nakai induces apoptosis in RC-58T/h/SA# 4 primary human prostate cancer cells via a mitochondria-related caspase pathway
  58. Decursin from Angelica gigas Nakai Inhibits B16F10 Melanoma Growth Through Induction of Apoptosis
  59. Decursin from Angelica gigas Nakai regulates CXCR7 expression and its downstream signaling in gastric cancer cells
  60. Decursin from Angelica gigas suppresses RANKL-induced osteoclast formation and bone loss
  61. Decursin in Angelica gigas Nakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR‐RES Ovarian Cancer Cells via Inhibition of P‐glycoprotein Expression
  62. Decursin in Angelica gigas Nakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADRâ RES Ovarian Cancer Cells via Inhibition of Pâ glycoprotein Expression
  63. Decursin induces apoptosis by regulating AMP-activated protein kinase and Bax/Bcl-2 pathway in HepG2 cell line
  64. Decursin induces apoptosis in glioblastoma cells, but not in glial cells via a mitochondria-related caspase pathway
  65. Decursin inhibited proliferation and angiogenesis of endothelial cells to suppress diabetic retinopathy via VEGFR2
  66. Decursin inhibits EC109 cells proliferation via suppression of JAK2/STAT3 signaling pathway
  67. Decursin inhibits growth of human bladder and colon cancer cells via apoptosis, G1-phase cell cycle arrest and extracellular signal-regulated kinase activation
  68. Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-κB activation in macrophages
  69. Decursin inhibits osteoclastogenesis by downregulating NFATc1 and blocking fusion of pre-osteoclasts
  70. Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation
  71. Decursin inhibits the growth of HepG2 hepatocellular carcinoma cells via Hippo/YAP signaling pathway
  72. Decursin inhibits tumor growth, migration and invasion through the regulation of CXCR7 expression in gastric cancer
  73. Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression
  74. Decursin inhibits UVB-induced MMP expression in human dermal fibroblasts via regulation of nuclear factor-κB
  75. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function
  76. Decursin Inhibits VEGF-Mediated Inner Blood-Retinal Barrier Breakdown by Suppression of VEGFR-2 Activation
  77. Decursin Inhibits VEGF-mediated inner blood—retinal barrier breakdown by suppression of VEGFR-2 activation
  78. Decursin isolated from Angelica gigas Nakai rescues PC12 cells from amyloid-protein-induced neurotoxicity through Nrf2-mediated upregulation of heme oxygenase …
  79. Decursin mediated protection on cisplatin-induced nephrotoxicity in SD rats and BDF1 mice
  80. Decursin prevents cisplatin-induced apoptosis via the enhancement of antioxidant enzymes in human renal epithelial cells
  81. Decursin prevents TPA-induced invasion through suppression of PKCα/p38/NF-κB-dependent MMP-9 expression in MCF-7 human breast carcinoma cells
  82. Decursin reduce radio-resistance of hypoxic regions under the proton beam therapy by induced HIF-1α degradation
  83. Decursin reduces reactive oxygen species and inhibits cisplatin-induced apoptosis in rat renal tubular epithelial cells
  84. Decursin safety from root of Angelica gigas in rats
  85. Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of β-catenin
  86. Decursin synergistically enhances TRAIL-induced apoptosis through CHOP dependent DR5 signaling in TRAIL resistant lung cancer cells
  87. Decursin was Accelerated Human Lung Cancer Cell Death Caused by Proton Beam Irradiation via Blocking the p42/44 MAPK pathway
  88. Decursin, a coumarin compound, inhibits the growth of human hepatoma cells involving cell cycle arrest, apoptosis, and autophagy
  89. Decursin, an Active Compound Isolated from Angelica gigas, Inhibits Fat Accumulation, Reduces Adipocytokine Secretion and Improves Glucose Tolerance in Mice …
  90. Decursin, Decursinol angelate Decursinol inhibit pro-inflammatory cytokine expression on β-amyloid peptide-induced THP-1 cells
  91. Decursin: a cytotoxic agent and protein kinase C activator from the root of Angelica gigas
  92. Decursinol and Decursin protect primary cultured rat cortical cells from glutamate‐induced neurotoxicity
  93. Determination of Decursin from eight kinds of Angelica plants by HPLC [J]
  94. Determination of pyranocoumarin compounds Decursin, Decursinol angelate and Decursinol simultaneously in mouse plasma and tumor tissue by liquid-liquid …
  95. Discovery of Decursin from Korean Angelica gigas as a novel anti-androgen signaling compound
  96. Effect of a (S)-(+)-Decursin Derivative,(S)-(+)-3-(3, 4-dihydroxy-phenyl)-acrylic Acid 2, 2-dimethyl-8-oxo-3, 4-dihydro-2H, 8H-pyrano [3, 2-g]-chromen-3-yl-ester on …
  97. Effect of Decursin on the Expression of β-Catenin and Matrix Metalloproteinase-7 in Prostate Cancer Cell Lines
  98. Effect of Decursin on the pharmacokinetics of theophylline and its metabolites in rats
  99. Effect of N, P and K Application on the Contents of the Decursin and Total Sugar in Angelicae gigantis Radix
  100. Effect of yield and Decursin content according to the accumulative temperature and seedling size in cultivation areas of Angelica gigas Nakai
  101. Effects of Angelica gigas Nakai on the production of Decursin‐ and Decursinol angelate‐enriched eggs
  102. Effects of Decursin and Decursinol on the germination and growth of plants
  103. Enantioselective syntheses of Decursinol angelate and Decursin
  104. Enantioselective total syntheses of (+)-Decursin and related natural compounds using catalytic asymmetric epoxidation of an enone
  105. Enantioselective total syntheses of novel PKC activator (+)-Decursin and its derivatives using catalytic asymmetric epoxidation of an enone
  106. Enhanced accumulation of Decursin and Decursinol angelate in root cultures and intact roots of Angelica gigas Nakai following elicitation
  107. Environmental variation of Decursin content in Angelica gigas
  108. Erratum to ”Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid 𝛽-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of …
  109. Erratum to “Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid β-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of …
  110. Far infared effect on Decursin, Decursinol angelate and antioxidant activity in Angelica gigas Nakai
  111. First-pass metabolism of Decursin, a bioactive compound of Angelica gigas, in rats
  112. First-pass metabolism of Decursin, a bioactive compound of Angelica gigas, in rats
  113. Hypopigmentary action of dihydropyranocoumarin D2, a Decursin derivative, as a MITF-degrading agent
  114. In vitro and in vivo antifungal activities of Decursin and Decursinol angelate isolated from Angelica gigas against Magnaporthe oryzae, the causal agent of rice blast
  115. In Vitro inhibitory potential of Decursin and Decursinol angelate on the catalytic activity of cytochrome P-450 1A1/2, 2D15, and 3A12 isoforms in canine hepatic …
  116. In vitro metabolism of pyranocoumarin isomers Decursin and Decursinol angelate by liver microsomes from man and rodents
  117. In vivo Anti-Cancer Activity of Korean Angelica Gigas and its Major Pyranocoumarin Decursin
  118. Inhibition of angiogenic attributes by Decursin in endothelial cells and ex vivo rat aortic ring angiogenesis model
  119. Inhibition of cyclooxygenase-2-dependent survivin mediates Decursin-induced apoptosis in human KBM-5 myeloid leukemia cells
  120. Inhibitory Effect of Decursin on Retinal Neovasularization in Mouse Model of Oxygn-induced Retinopathy
  121. Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic Decursin and its derivatives and their structure–activity relationship in human K562 …
  122. Microbial metabolism. Part 8. The pyranocoumarin, Decursin
  123. MP70-14 EFFECTS OF Decursin EXTRACTED FROM ANGELICA GIGAS VIA NRF2/HO-1 SIGNALLING PATHWAY IN CRYPTORCHIDISM-INDUCED …
  124. New syntheses of demethylsuberosin, xanthyletin,(±)-Decursinol,(+)-marmesin,(−)-nodakenetin,(±)-Decursin, and (±)-prantschimgin
  125. NF-E2 related factor 2 activation induction by Decursin and Decursinol angelate protect against bete-amyloid-peptide-induced oxidative stress in PC12 cells
  126. Optimal Extraction and Purification of Decursin from Angelica gigas Nakai
  127. PHARMACEUTICAL AND COSMETIC COMPOSITION COMPRISING OF Decursin FOR INCREASING THE NUMBERS OF HUMAN KERATINOCYTE …
  128. Pharmacokinetic Study of Decursin, the Major Compound of ESP-102, in Rats
  129. Physicochemical characterization and toxicity of Decursin and their derivatives from Angelica gigas
  130. Pilot-scale subcritical-water extraction of nodakenin and Decursin from Angelica gigas Nakai
  131. Potent antiandrogen and androgen receptor activities of an Angelica gigas–containing herbal formulation: identification of Decursin as a novel and active compound …
  132. Potent inhibition of monoamine oxidase A by Decursin from Angelica gigas Nakai and by wogonin from Scutellaria baicalensis Georgi
  133. Potential of Decursin to inhibit the human cytochrome P450 2J2 isoform
  134. Profiling of skin anti-aging related proteins in human dermal fibroblasts by Decursin in Angelica gigas Nakai
  135. Protective effect of Decursin and Decursinol angelate-rich Angelica gigas Nakai extract on dextran sulfate sodium-induced murine ulcerative colitis
  136. Protective effect of Decursin extracted from Angelica gigas in male infertility via Nrf2/HO-1 signaling pathway
  137. Protective effects of Decursin and Decursinol angelate against amyloid β-protein-induced oxidative stress in the PC12 cell line: the role of Nrf2 and antioxidant …
  138. Quantitative determination of Decursin, Decursinol angelate, and Decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC
  139. Rapid and Efficient Separation of Decursin and Decursinol Angelate from Angelica gigas Nakai using Ionic Liquid,(BMIm) BF4, Combined with Crystallization
  140. Recovery from the two-generation reproductive toxicity in sprague-dawley rats by treatment with Decursin and Decursinol angelate
  141. Retracted: Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid β-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of …
  142. Role of Decursin in TNF-α-stimulated migration, invasion, and matrix metalloproteinase-9 induction in vascular smooth muscle cells
  143. Simultaneous determination of Decursin, Decursinol angelate, nodakenin, and Decursinol of angelica gigas nakai in human plasma by UHPLC-MS/MS: application to …
  144. Single oral dose pharmacokinetics of Decursin and Decursinol angelate in healthy adult men and women
  145. Single oral dose pharmacokinetics of Decursin, Decursinol angelate, and Decursinol in rats
  146. Stereostructures of Decursin, decursidin, and a new coumarin isolated from Angelica decursiva
  147. Studies on coumarins from the root of Angelica decursiva FR. et SAV. I. The structure of Decursin and decursidin
  148. Studies on coumarins from the root of Angelica decursiva FR. et SAV. II. Sterostructures of Decursin, decursidin, and other new pyranocoumarin derivatives.
  149. Studies on coumarins from the root of Angelica decursiva FR. et SAV.: II. stereostructures of Decursin, Decursidin, and other new Pyranocoumarin derivatives
  150. Synthesis and biological evaluation of Decursin, prantschimgin and their derivatives
  151. Synthesis and evaluation of (+)-Decursin derivatives as inhibitors of the Wnt/β-catenin pathway
  152. Synthesis of (S)-(+)-Decursin and its analogues as potent inhibitors of melanin formation in B16 murine melanoma cells
  153. The constitution of Decursin, a new coumarin isolated from the root of Angelica decursiva FR. et SAV.(umbelliferae)
  154. The in vitro and in vivo anti-tumor effect of Decursin in estrogen receptor-negative human breast cancer cells occurs via downregulation of Akt signaling pathway
  155. The in vitro and in vivo antitumor effect of Decursin in estrogen receptor-negative human breast cancer cells via downregulation of Akt signaling pathway.
  156. The Neuroprotective Effects of Decursin Isolated from Angelica gigas Nakai Against Amyloid β-Protein-Induced Apoptosis in PC 12 Cells via a Mitochondria-Related …
  157. The optimization of microwave‐assisted extraction of Decursin from Angelica gigas Nakai root
  158. Transport of Decursin and Decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability
  159. Variation of Decursin contents of rootages in floral inhibition cultured Angelica gigas Nakai

Related Posts

Shopping Cart
Scroll to Top